2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
The 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias are now available, published in the European Heart Journal and Atherosclerosis by the European Society of Cardiology and EAS. The guidance includes sections on: the evaluation of laboratory lipid and apolipoprotein parameters; treatment targets; lifestyle modifications to improve the plasma lipid profile; drugs for treatment of hypercholesterolaemia and hypertriglyceridaemia; drugs affecting HDL-cholesterol; managing dyslipidaemias in different clinical settings; monitoring lipids and enzymes in patients on lipid-lowering therapy; and strategies to encourage adoption of healthy lifestyle changes and lipid-modifying therapies.
Welcome to the Central & Eastern European Symposium on FH
Register now to take part in this FHSC meeting, taking place on November 25-27, 2016 in Warsaw, Poland. The Symposium will summarize and discuss up-to-date information on FH and bring together leaders in the field.
One of the main themes of the Symposium is to facilitate collaboration between experts, with particular focus on the region of Central and Eastern Europe, and to invite them for closer cooperation with EAS in the Central & Eastern European Key Opinion Leader Summit.
Register now! The organizers look forward to welcoming you and your colleagues to Warsaw - the perfect setting work together towards improving identification and providing better treatment for FH patients throughout Europe.